Opioid-NMDA receptor interactions may clarify conditioned (associative) components of opioid analgesic tolerance

Neuroscience and Biobehavioral Reviews

Volumn 25, Issue 4, 2001, Pages 343-353

  Bespalov, Anton Y ^a   Zvartau, Edwin E ^a   Beardsley, Patrick M ^b  

^a PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Conditioning; NMDA receptors; Opioid analgesia; Tolerance

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ADRENALIN; DIAMORPHINE; DIZOCILPINE; FENTANYL; GLUTAMATE RECEPTOR AGONIST; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OPIATE; OPIATE AGONIST; OPIATE ANTAGONIST;

ANALGESIA; ANIMAL EXPERIMENT; ASSOCIATION; CONDITIONING; CONTROLLED STUDY; DOG; DRUG TOLERANCE; HYPERALGESIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

ANALGESICS, OPIOID; ANIMALS; ASSOCIATION LEARNING; CONDITIONING, OPERANT; DRUG TOLERANCE; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, OPIOID;

EID: 0034938481     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(01)00018-5     Document Type: Review

References (122)

1. Pharmacological characterization of the sensitization to the rate-decreasing effects of naltrexone induced by acute opioid pretreatment in rats
2. Drug-test interactions as a factor in the development of tolerance to the analgesic effect of morphine
3. On conditioned reactions formed under the action of humoral factors
4. Temporal and spatial characteristics of tonically active neurons of the primate's striatum
5. Morphine tolerance as habituation
6. Effects of NMDA receptor channel blockers, dizocilpine and memantine, on the development of opiate analgesic tolerance induced by repeated morphine exposures or social defeats in mice
7. Effects of short-acting glycine site NMDA receptor antagonist, MRZ 2/576, on development of morphine analgesic tolerance in mice
8. Antinociceptive activity of combination of morphine and NMDA receptor antagonists depends on the inter-injection interval
9. receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat
10. Spinal antinociceptive and nociceptive effects of ODAP analogues: a pharmacological analysis
11. Prolongation of morphine analgesia by competitive NMDA receptor antagonist D-CPPene in rats
12. Conditioned activation of electrical self-stimulation of the brain: model of situational craving to narcotics
13. Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and self-administrative behavior
14. Loss of antiallodynic and antinociceptive spinal/supraspinal morphine synergy in nerve-injured rats: restoration by MK-801 or dynorphin antiserum
15. Morphine as a conditioned stimulus in a conditioned emotional response paradigm
16. The relative salience of morphine and contextual cues as conditioned stimuli
17. Pavlovian control of cross-tolerance between pentobarbital and ethanol
18. Contingent tolerance to the anorexigenic effects of amphetamine
19. Cross-tolerance of associative and nonassociative morphine tolerance in the rat with mu- and kappa-specific opioids
20. Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated
21. Unsignaled morphine delivery does not disrupt the development of associative tolerance in the rat
22. Time-related roles of excitatory amino acid receptors during persistent noxiously evoked responses of rat dorsal horn neurones
23. Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a μ opioid
24. Modulation by dopamine D1-like receptors of synaptic transmission and NMDA receptors in rat nucleus accumbens is attenuated by the protein kinase C inhibitor Ro 32-0432
25. Classically conditioned responses in opioid and cocaine dependence: a role in relapse?
26. Limbic activation during cue-induced cocaine craving
27. The elusive nature of intrinsic activity
28. Effect of actinomycin D on morphine tolerance
29. Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated opioid receptor functions
30. Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons
31. Role of conditioned reinforcers in the initiation, maintenance and extinction of drug-seeking behavior
32. Repetitive opioid abstinence causes progressive hyperalgesia sensitive to N-methyl-D-aspartate receptor blockade in the rat
33. The effect of intrinsic efficacy on opioid tolerance
34. Tolerance and cross-tolerance to the discriminative stimulus properties of fentanyl and morphine
35. Changes in sensitivity to the rate-decreasing effects of opioids in pigeons treated acutely or chronically with l-alpha-acetylmethadol
36. Multiple effects of phorbol esters in the rat spinal dorsal horn
37. Sensitization to apomorphine in pigeons is due to conditioning, subject to generalization but resistant to extinction
38. Dual ultrastructural localization of m-opioid receptors and NMDA-type glutamate receptors in the shell of the rat nucleus accumbens
39. -aspartate receptor antagonists potentiate morphine's antinociceptive effect in the rat
40. The basal ganglia and adaptive motor control
41. Alcohol is an effective cue in the conditional control of tolerance to alcohol
42. Associative and non-associative mechanisms of morphine analgesic tolerance are neurochemically distinct in the rat spinal cord
43. Modulation of intracranial self-stimulation threshold by drug-associated contextual cues
44. The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal-Medication development issues for opiate addiction
45. Catecholamines, sympathomimetic drugs and adrenergic receptor antagonists (Chapter 10)
46. Temporal factors influencing the development of acute tolerance to opiates
47. Conditioning of an interoceptive drug stimulus to different exteroceptive contexts
48. Conditioning of morphine-induced enhancement of motor activity
49. Experience as a factor in the development of tolerance to the analgesic effect of morphine
50. Configuration and combination laws in conditioning with compound stimuli
51. Response-reinforcement learning is dependent on N-methyl-D-aspartate receptor activation in the nucleus accumbens core
52. Magnitude of acute tolerance to opioids is not related to their potency
53. -aspartate antagonists and drug discrimination
54. Increased N-methyl-D-aspartate (NMDA) activity in the mouse spinal cord following morphine does not mediate opioid withdrawal
55. Acute tolerance associated with a single opiate administration: involvement of N-methyl-D-aspartate-dependent pain facilitatory systems
56. Opiate tolerance to daily heroin administration: an apparent phenomenon associated with enhanced pain sensitivity
57. Long lasting increased pain sensitivity in rat following exposure to heroin for the first time
58. Acute effects of morphine on the expression of mRNAs for NMDA receptor subunits in the rat hippocampus, hypothalamus and spinal cord
59. Conditioned slowing of stomach emptying produced by Pavlovian pairings of a drug CS or a place with lithium chloride
60. Pairings of a drug or place conditioned stimulus with lithium chloride produce conditioned sickness, not antisickness
61. Alteration of spinal protein kinase C expression and kinetics in morphine, but not clonidine, tolerance
62. Attenuation of nociceptive responses by ACEA-1021, a competitive NMDA receptor/glycine site antagonist, in the mice
63. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain
64. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions
65. Delayed application of MK-801 attenuates development of morphine tolerance in rats
66. mu-opioid receptors modulate NMDA receptor-mediated responses in nucleus accumbens neurons
67. Inflammation-induced up-regulation of protein kinase Cγ immunoreactivity in rat spinal cord correlates with enhanced nociceptive processing
68. Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions
69. N-methyl-D-aspartate receptor structure and function
70. Analgesia and decrement in operant performance in socially defeated mice: selective cross-tolerance to morphine and antagonism by naltrexone
71. Conditioning of discriminable stimuli produced by morphine
72. An analysis of the 'tolerance' which develops to analgetic electrical stimulation of the midbrain periaqueductal grey in freely moving rats
73. Conditioning of morphine-induced taste aversion and analgesia
74. Limbic-motor integration
75. Inhibition of protein kinase C, but not of protein kinase A, blocks the development of acute antinociceptive tolerance to an intrathecally administered μ-opioid receptor agonist in the mouse
76. Interactions between mu and kappa opioid agonists in the rat drug discrimination procedure
77. Interactions between the discriminative stimulus effects of mu and kappa opioid agonists in the squirrel monkey
78. Enhancement of the antiallodynic and antinociceptive efficacy of spinal morphine by antisera to dynorphin A (1-13) or MK-801 in a nerve-ligation model of peripheral neuropathy
79. Conditioning factors in drug abuse: can they explain compulsion?
80. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive
81. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive
82. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive
83. Centrally acting drugs act as conditioned stimuli in a conditioned suppression of drinking task
84. Development of context-specific tolerance to morphine: support for a dual-process interpretation
85. Conditioning as a critical determinant of sensitization induced by psychomotor stimulants
86. Cross-tolerance and enhanced sensitivity to the response rate-decreasing effects of opioids with varying degrees of efficacy at the mu receptor
87. The role of context and conditioning in behavioral sensitization to cocaine
88. Serotonin involvement in the discriminative stimulus effects of mu and kappa opioids in rats
89. Pharmacological generality of the Avfail effect
90. Heart rate conditioning with pentobarbital as a conditioned stimulus and amphetamine as an unconditioned stimulus
91. When pentobarbital is the conditioned stimulus and amphetamine is the unconditioned stimulus, conditioning depends on the type of conditioned response
92. Associative predispositions
93. Cocaine-seeking produced by experimenter-administered drug injections: dose-effect relationships in rats
94. Enhanced sensitivity to behavioral effects of naltrexone in rats
95. Low-affinity NMDA receptor channel blockers attenuate initiation of morphine i.v. self-administration in drug-naive mice
96. Disruption of tolerance to the ataxic effect of ethanol by an extraneous stimulus
97. Reversal of ethanol tolerance by a novel stimulus
98. Drug anticipation and drug tolerance
99. Evidence from rats that morphine tolerance is a learned response
100. Morphine tolerance acquisition as an associative process
101. Pharmacological conditioning and drug effects
102. Behavioral and physiological detection of classically-conditioned blood pressure reduction
103. Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants
104. Naloxone-precipitated acute opioid withdrawal syndrome after epidural morphine
105. Morphine self-administration, food-reinforced, and avoidance behaviors in rhesus monkeys
106. Possible involvement of protein kinases in physical dependence on opioids: studies using protein kinase inhibitors, H-7 and H-8
107. Some behavioural signs of morphine withdrawal blocked by conditional stimuli
108. Behavioral classification of excitatory amino acids receptors in mouse spinal cord
109. Protein kinase C potentiation of currents from mouse zeta1/epsilon2 NMDA receptors expressed in Xenopus oocytes depends on f-actin/g-actin cycling
110. Effect of protein kinase-C activation on the Mg(2+)-sensitivity of cloned NMDA receptors
111. Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats
112. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants
113. Classification of multiple morphine and enkephalin binding sites in the central nervous system
114. Subunit- and site-specific pharmacology of the NMDA receptor channel
115. Effects of acute morphine pretreatment on the rate-decreasing and antagonist activity of naloxone
116. The spinal biology in humans and animals of pain states generated by persistent small afferent input
117. Morphine modulates excitatory amino acid-induced activity in the mouse spinal cord: Short-term effects on N-methyl- D-aspartate (NMDA) and long-term effects on kainic acid
118. Effects of 5-HT receptor antagonists on morphine-induced tolerance in mice
119. On the role of the conditioned adaptation in establishing hyperergic responses